NIKYANG | USP-4 Dissolution Separation | Experts

Search Results for: aaps

Samir Interview in AAPS 2019

BE-Special The road to R&D of new drugs in China, Part 2 Media interview Why is FDA inspection and approval so important? http://www.nikyang.com/wp-content/uploads/video/interview/SamirSyncColored_Q4.mp4 Why is SPS able to stand out from the competition? http://www.nikyang.com/wp-content/uploads/video/interview/SamirSyncColored_Q6.mp4 How does SPS help China’s generics industry improve their products? http://www.nikyang.com/wp-content/uploads/video/interview/SamirSyncColored_Q8.mp4 What advantages does SPS offer to customers? http://www.nikyang.com/wp-content/uploads/video/interview/SamirSyncColored_Q9.mp4 What are the competitive advantages of SPS

Read More »

Diane Interview in AAPS 2019

BE-Special The road to R&D of new drugs in China – 1 Media interview The US FDA recommends USP4 as the dissolution priority test method. Does the Chinese pharmaceutical industry see its value? http://www.nikyang.com/wp-content/uploads/video/interview/DianeSyncColored_Q2.mp4 How to overcome the difficulties encountered in testing the dissolution of microspheres?   http://www.nikyang.com/wp-content/uploads/video/interview/DianeSyncColored_Q4.mp4 What method will you recommend to test the microsphere dissolution? http://www.nikyang.com/wp-content/uploads/video/interview/DianeSyncColored_Q5.mp4 What

Read More »

the-essentials

Previous Next The essentials Diane J. Burgess Board of Trustees Distinguished Professor of Pharmaceutics University of Connecticut BE & USP4 – AAPS 2019 interview page AAPS 2019 Samir Haddouchi Managing Director | SPS Pharma Services China + CRO + NIKYANG Yu Zhao, Yolanda Zhao Bioequivalence Experimenter | NIKYANG Overview: BE and USP 4 in China Carmen Guguta Product Manager |

Read More »
Online Message